글로벌 외상성 뇌 손상 치료 시장 – 2030년까지의 산업 동향 및 예측

외상성 뇌 손상 치료 시장 분석 및 규모

외상성 뇌 손상 치료 약물 시장 성장은 이러한 부상의 치료 및 교정에 필요한 광범위한 수술 절차와 같은 주요 요인에 의해 주도됩니다. 나아가, 다양한 기술 혁신 및 발전, 광범위한 연구 및 개발 활동, 외상성 뇌 손상 개발을 위해 수행되는 많은 양의 임상 시험 도 2023-2030년 예측 기간 동안 외상성 뇌 손상 치료 시장 성장을 견인할 것으로 예상됩니다. 그러나 저개발 경제권에서 다양한 개인과 소비자가 이 치료법에 대한 인식이 부족하여 2023-2030년 예측 기간 동안 외상성 뇌 손상 치료 시장 성장이 제한됩니다. 또한, 높은 가격과 지연된 진단 결론은 위에서 언급한 예측 기간 동안 시장 성장에 도전할 것입니다. 또한, 스포츠로 인한 교통사고 및 부상 사례가 증가함에 따라 위에서 언급한 예측 기간 동안 외상성 뇌 손상 치료 시장에 충분한 기회가 생길 것입니다.

Data Bridge Market Research는 2022년에 34억 6천만 달러였던 글로벌 외상성 뇌 손상 치료 시장이 2030년까지 55억 3천만 달러로 급증할 것으로 분석했으며, 예측 기간 동안 6.20%의 CAGR을 기록할 것으로 예상합니다. 약물에 대한 수요가 증가함에 따라 "병원"이 외상성 뇌 손상 치료 시장의 최종 사용자 부문을 지배할 것으로 예상됩니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

외상성 뇌 손상 치료 시장 범위 및 세분화

시장 정의

외상성 뇌 손상 치료는 다양한 정도의 외상성 뇌 손상을 치료하기 위해 개발된 의료 산업에서 사용 가능한 다양한 치료 방법 중 하나입니다. 주로, 이 치료에는 낮은 등급의 부상을 치료하기 위해 설계된 경미한 약물이 포함됩니다.

글로벌 외상성 뇌 손상 치료 시장 역학

운전자

• 뇌 손상 사례 증가

외상성 뇌 손상 징후와 증상은 두부 손상 후에 발생할 수 있으며, 때로는 나타나기까지 며칠 또는 몇 주가 걸릴 수 있습니다. 외상성 뇌 손상에는 경미, 중등도, 중증의 세 가지 수준이 있습니다. 경미한 부상을 입은 환자는 일시적인 뇌진탕을 겪으며, 드물게는 장기적인 기능적 뇌 이상을 초래할 수 있습니다. 이는 시장 성장을 촉진합니다.

사고, 낙상, 둔기적 외상, 기타 뇌의 물리적 손상으로 인한 뇌 손상 사례가 증가하고 있고, 외상성 뇌 손상 치료 시장의 확립과 성장을 위한 투자가 계속되고 있기 때문입니다.

• 인구 증가

Due to growing population and rising per capita income, which has changed consumer demand for highly sophisticated and technologically advanced products and equipment, the traumatic brain injury market has been growing across all segments and geographical locations. This has served as a driving force for the market. Also, number of patients needing treatment for traumatic brain injuries has increased due to increase in vehicle accidents, sports-related injuries, falls, gunshot wounds, and injuries from domestic violence. One of the main reasons for rise in demand for brain surgery is ageing population and neurological issues they experience as they age.

• Rising number of clinical trials for Traumatic brain injuries treatment

The large number of pipeline drugs and new drug approvals is the major factor driving the global traumatic brain injury market growth. Due to the rising prevalence of traumatic brain injury (TBI), the number of drugs under development for its treatment is expanding at a significant rate. Most of the drugs that are in the last phases of development and expected to get marketing approval during the forecast period.  Furthermore, there are a few drugs in the pipeline that demonstrate a decent efficacy and safety profile. Once these drugs are affirmed, they will expand the number of products in the market, and fuel the traumatic brain injury therapeutics market size growth.

Opportunities

• Rising number of health awareness campaigns and programs

The global market for treatment of traumatic brain injuries has opportunities due to rising number of health awareness campaigns and programs that have inspired individuals to take better care of their health and to be more aware of diseases that can be brought on by using various goods. Additionally, expansion of medical facilities worldwide and financial commitments from both public and private sectors have enabled the market for treating traumatic brain injuries to expand significantly. Such increasing applications will create lucrative opportunities in the market, thereby supplementing the market growth.

Restraints/Challenges

On the other hand, factors such as high startup costs for traumatic brain injury treatment businesses, prevents many new players from entering the market. Moreover, the strict and restrictive system of laws and regulations put in place by governments of various nations also serves as a major impediment to growth of treating traumatic brain injury market. The market growth has also been hampered by general public's lack of knowledge about brain injuries and their treatments. In addition to that, some have been discouraged from receiving such treatment due to delayed results of the diagnosis.

This traumatic brain injuries treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Traumatic brain injuries treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In August 2021, Arkansas Children’s Hospital agrees to acquire TRIUX™ neo for functional brain imaging. This will help in the detection capability when diagnosing patients across a wide spectrum including epilepsy, brain tumors, traumatic brain injury, post-traumatic stress disorder, and autism.

Global Traumatic Brain Injuries Treatment Market Scope

The traumatic brain injuries treatment market is segmented on the basis of treatment, route of administration, patient age, gender, cause of injury and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Immediate Emergency Care
• Medications
• Diuretics
• Anti-Seizure Drugs
• Coma-Inducing Drugs
• Anti-Anxiety Agent
• Anti-Depressants
• Anti-Psychotics
• Analgesic
• Anti-Convulsant
• Anti-Coagulants
• Surgery
• Clotted Blood Removal
• Repairing Skull Fractures
• Brain Bleeding Treatment
• Window Opening In Skull And Rehabilitation

Route of Administration

• Parenteral
• Oral

Patient Age

• Children
• Teenager
• Elder

Gender

• Male
• Female

Cause of Injury

• Falls
• Motor Vehicle Traffic
• Sports
• Others

End-User

• Hospitals
• Neurology Clinics
• Independent Pharmacies
• Others

Global Traumatic Brain Injuries Treatment Market Analysis/Insights

The traumatic brain injuries treatment market is analysed and market size insights and trends are provided by country, treatment, route of administration, patient age, gender, cause of injury, and end-users as referenced above.

The countries covered in the global traumatic brain injuries treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.   

North America is expected to witness positive growth due to the significant volume of target population and increasing number of individuals suffering from traumatic brain injuries in this region.

Asia-Pacific is projected to exhibit the highest growth rate during the forecast period due to the rising cases of traffic accidents and road injuries in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global traumatic brain injuries treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global traumatic brain injuries treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global traumatic brain injuries treatment market. The data is available for historic period 2015-2020.

Competitive Landscape and Global Traumatic Brain Injuries Treatment Market Share Analysis

The global traumatic brain injuries treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global traumatic brain injuries treatment market.

Some of the major players operating in the global traumatic brain injuries treatment market are:

• Zimmer Biomet (U.S.)
• Neuren Pharmaceuticals (Australia)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Medicortex Finland Oy (Finland)
• AMARANTUS BIOSCIENCE HOLDINGS, INC. (U.S.)
• Stemedica Cell Technologies, Inc. (U.S.)
• BANYAN BIOMARKERS, INC. (U.S.)
• BioDirection (U.S.)
• QuesGen Systems, Inc. (U.S.)
• Neural Analytics, Inc. (U.S.)
• Oculogica, VASOPHARM (U.S.)
• Johnson & Johnson Services Inc. (U.S.)
• Smith & Nephew (U.K.)
• Stryker (U.S.)
• Medtronic (U.S.)
• Bioretec Ltd. (Finland)
• B. Braun Melsungen AG (Germany)
• Arthrex, Inc. (U.S.)
• Wright Medical Group N.V. (U.S.)
• NuVasive Inc. (U.S.)
• Advance Orthopaedic Solutions (U.S.)
• Arthrosurface (U.S.)
• CONMED Corporation(미국)

SKU-24969